PSG

PSG is committed to educating the marketplace with timely information concerning the pharmacy industry. Because this industry is rapidly evolving, it is vital that our clients have access to fact-driven information. PSG understands that it can be difficult to navigate drug management challenges. PSG’s extensive knowledge of the pharmaceutical industry enables us to help our clients anticipate the shifting landscape and turn challenges into opportunities.

Leveraging your hospital’s pharmacy and clinical assets to offset rising pharmacy benefit costs

US prescription drug costs are rising at a significant rate with spending on medications increasing 13.1% in 2014 alone, according to IMS Health, the highest level since 2001. Real per capita spending on drugs has tripled from $339 in 1995 to $995 in 2014.
Read More

Practical tips to prepare covered entities

HRSA plans to continue the current pace of 340B audits of covered entities in 2016.
Read More

HRSA 340B Mega-Guidance

The “mega-guidance” actually began as a “mega-reg.” The difference? The “mega-reg” HRSA announced in January 2014 was to be a series of legislative rules.
Read More

Understanding Specialty Pharmacy Management and Cost Control

The goal of this paper is to provide plan sponsors with an understanding of what specialty pharmacy is and the various approaches that may mitigate the double-digit growth of these high cost drugs
Read More

Disintermediation

How To Improve the Performance of Your Pharmacy Program By Insourincg PBM Functions
Read More

PSG National Consumer-Driven Health Plan Pharmacy Benefit Survey

As anticipated, CDH plans are still in the minority, with ~22% of national employers offering them. Among those that do offer CDH, most (~72%) are medium-large to large employers (typical 5000+ employees).
Read More

An Evaluation of Payer Satisfaction with Specialty Pharmacy Providers

50% of respondents reported that specialty pharmaceuticals represented > 8% of overall pharmacy costs
Read More